NEOTERREX MINERALS INC (NTX.CA) Fundamental Analysis & Valuation

TSX-V:NTX • CA6409801082

Current stock price

0.12 CAD
-0.01 (-4%)
Last:

This NTX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NTX.CA Profitability Analysis

1.1 Basic Checks

  • NTX had negative earnings in the past year.
  • NTX had a negative operating cash flow in the past year.
  • In the past 5 years NTX always reported negative net income.
  • In the past 5 years NTX always reported negative operating cash flow.
NTX.CA Yearly Net Income VS EBIT VS OCF VS FCFNTX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 -1M -2M -3M

1.2 Ratios

  • With a Return On Assets value of -43.03%, NTX is not doing good in the industry: 61.51% of the companies in the same industry are doing better.
  • NTX has a Return On Equity (-51.98%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -43.03%
ROE -51.98%
ROIC N/A
ROA(3y)-45.51%
ROA(5y)-35.95%
ROE(3y)-51.24%
ROE(5y)-39.98%
ROIC(3y)N/A
ROIC(5y)N/A
NTX.CA Yearly ROA, ROE, ROICNTX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 -20 -40 -60

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NTX.CA Yearly Profit, Operating, Gross MarginsNTX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025

7

2. NTX.CA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, NTX has more shares outstanding
  • NTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NTX.CA Yearly Shares OutstandingNTX.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 20M 40M 60M 80M
NTX.CA Yearly Total Debt VS Total AssetsNTX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 2M 4M 6M

2.2 Solvency

  • NTX has an Altman-Z score of 6.35. This indicates that NTX is financially healthy and has little risk of bankruptcy at the moment.
  • NTX has a Altman-Z score (6.35) which is in line with its industry peers.
  • There is no outstanding debt for NTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.35
ROIC/WACCN/A
WACCN/A
NTX.CA Yearly LT Debt VS Equity VS FCFNTX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 2M -2M 4M

2.3 Liquidity

  • A Current Ratio of 5.80 indicates that NTX has no problem at all paying its short term obligations.
  • The Current ratio of NTX (5.80) is better than 73.33% of its industry peers.
  • NTX has a Quick Ratio of 5.80. This indicates that NTX is financially healthy and has no problem in meeting its short term obligations.
  • NTX's Quick ratio of 5.80 is fine compared to the rest of the industry. NTX outperforms 73.46% of its industry peers.
Industry RankSector Rank
Current Ratio 5.8
Quick Ratio 5.8
NTX.CA Yearly Current Assets VS Current LiabilitesNTX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 2M 4M 6M

0

3. NTX.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 39.16% over the past year.
EPS 1Y (TTM)39.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. NTX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • NTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NTX.CA Price Earnings VS Forward Price EarningsNTX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NTX.CA Per share dataNTX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 0.02 0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. NTX.CA Dividend Analysis

5.1 Amount

  • NTX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

NTX.CA Fundamentals: All Metrics, Ratios and Statistics

NEOTERREX MINERALS INC

TSX-V:NTX (4/10/2026, 7:00:00 PM)

0.12

-0.01 (-4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-06
Earnings (Next)05-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.99%
Ins Owner ChangeN/A
Market Cap9.94M
Revenue(TTM)N/A
Net Income(TTM)-1.52M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.4
P/tB 3.4
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.03%
ROE -51.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-45.51%
ROA(5y)-35.95%
ROE(3y)-51.24%
ROE(5y)-39.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.8
Quick Ratio 5.8
Altman-Z 6.35
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.34%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y50.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y65.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.97%
OCF growth 3YN/A
OCF growth 5YN/A

NEOTERREX MINERALS INC / NTX.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NEOTERREX MINERALS INC?

ChartMill assigns a fundamental rating of 2 / 10 to NTX.CA.


What is the valuation status for NTX stock?

ChartMill assigns a valuation rating of 0 / 10 to NEOTERREX MINERALS INC (NTX.CA). This can be considered as Overvalued.


What is the profitability of NTX stock?

NEOTERREX MINERALS INC (NTX.CA) has a profitability rating of 0 / 10.


What is the financial health of NEOTERREX MINERALS INC (NTX.CA) stock?

The financial health rating of NEOTERREX MINERALS INC (NTX.CA) is 7 / 10.